nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—PTGS2—pancreatic cancer	0.3	1	CbGaD
Etoricoxib—CYP2E1—Dacarbazine—pancreatic cancer	0.0605	0.15	CbGbCtD
Etoricoxib—CYP2E1—Tamoxifen—pancreatic cancer	0.0481	0.12	CbGbCtD
Etoricoxib—CYP1A2—Dacarbazine—pancreatic cancer	0.035	0.087	CbGbCtD
Etoricoxib—CYP2C19—Tamoxifen—pancreatic cancer	0.0302	0.075	CbGbCtD
Etoricoxib—CYP1A2—Tamoxifen—pancreatic cancer	0.0278	0.0692	CbGbCtD
Etoricoxib—CYP2C9—Tamoxifen—pancreatic cancer	0.0251	0.0624	CbGbCtD
Etoricoxib—CYP1A2—Erlotinib—pancreatic cancer	0.0237	0.0589	CbGbCtD
Etoricoxib—CYP2D6—Tamoxifen—pancreatic cancer	0.0229	0.057	CbGbCtD
Etoricoxib—CYP1A2—Fluorouracil—pancreatic cancer	0.0205	0.051	CbGbCtD
Etoricoxib—CYP2D6—Erlotinib—pancreatic cancer	0.0195	0.0485	CbGbCtD
Etoricoxib—CYP2C9—Fluorouracil—pancreatic cancer	0.0185	0.046	CbGbCtD
Etoricoxib—CYP3A4—Tamoxifen—pancreatic cancer	0.0146	0.0363	CbGbCtD
Etoricoxib—CYP3A4—Erlotinib—pancreatic cancer	0.0124	0.0308	CbGbCtD
Etoricoxib—CYP3A4—Irinotecan—pancreatic cancer	0.0112	0.0278	CbGbCtD
Etoricoxib—CYP2D6—Doxorubicin—pancreatic cancer	0.00962	0.0239	CbGbCtD
Etoricoxib—CYP3A4—Docetaxel—pancreatic cancer	0.00821	0.0204	CbGbCtD
Etoricoxib—CYP3A4—Sunitinib—pancreatic cancer	0.00817	0.0203	CbGbCtD
Etoricoxib—Vismodegib—SHH—pancreatic cancer	0.00645	0.929	CrCbGaD
Etoricoxib—CYP3A4—Doxorubicin—pancreatic cancer	0.00612	0.0152	CbGbCtD
Etoricoxib—Celecoxib—PTGS2—pancreatic cancer	0.000494	0.0711	CrCbGaD
Etoricoxib—Rash—Sunitinib—pancreatic cancer	0.000116	0.000583	CcSEcCtD
Etoricoxib—Dermatitis—Sunitinib—pancreatic cancer	0.000116	0.000582	CcSEcCtD
Etoricoxib—Abdominal distension—Doxorubicin—pancreatic cancer	0.000116	0.000581	CcSEcCtD
Etoricoxib—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000115	0.00058	CcSEcCtD
Etoricoxib—Urticaria—Fluorouracil—pancreatic cancer	0.000115	0.000579	CcSEcCtD
Etoricoxib—Headache—Sunitinib—pancreatic cancer	0.000115	0.000579	CcSEcCtD
Etoricoxib—Palpitations—Docetaxel—pancreatic cancer	0.000113	0.00057	CcSEcCtD
Etoricoxib—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000113	0.00057	CcSEcCtD
Etoricoxib—Weight increased—Epirubicin—pancreatic cancer	0.000113	0.000568	CcSEcCtD
Etoricoxib—Pancreatitis—Doxorubicin—pancreatic cancer	0.000113	0.000566	CcSEcCtD
Etoricoxib—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000112	0.000563	CcSEcCtD
Etoricoxib—Cough—Docetaxel—pancreatic cancer	0.000112	0.000563	CcSEcCtD
Etoricoxib—Angina pectoris—Doxorubicin—pancreatic cancer	0.000112	0.000563	CcSEcCtD
Etoricoxib—Hypersensitivity—Irinotecan—pancreatic cancer	0.000112	0.000561	CcSEcCtD
Etoricoxib—Pneumonia—Epirubicin—pancreatic cancer	0.000111	0.00056	CcSEcCtD
Etoricoxib—Hypertension—Docetaxel—pancreatic cancer	0.000111	0.000557	CcSEcCtD
Etoricoxib—Infestation NOS—Epirubicin—pancreatic cancer	0.000111	0.000556	CcSEcCtD
Etoricoxib—Infestation—Epirubicin—pancreatic cancer	0.000111	0.000556	CcSEcCtD
Etoricoxib—Bronchitis—Doxorubicin—pancreatic cancer	0.00011	0.000555	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00011	0.000552	CcSEcCtD
Etoricoxib—Arthralgia—Docetaxel—pancreatic cancer	0.000109	0.000549	CcSEcCtD
Etoricoxib—Chest pain—Docetaxel—pancreatic cancer	0.000109	0.000549	CcSEcCtD
Etoricoxib—Nausea—Sunitinib—pancreatic cancer	0.000109	0.000549	CcSEcCtD
Etoricoxib—Renal failure—Epirubicin—pancreatic cancer	0.000109	0.000547	CcSEcCtD
Etoricoxib—Asthenia—Irinotecan—pancreatic cancer	0.000109	0.000546	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000108	0.000545	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000108	0.000545	CcSEcCtD
Etoricoxib—Stomatitis—Epirubicin—pancreatic cancer	0.000108	0.000542	CcSEcCtD
Etoricoxib—Jaundice—Epirubicin—pancreatic cancer	0.000108	0.000542	CcSEcCtD
Etoricoxib—Conjunctivitis—Epirubicin—pancreatic cancer	0.000108	0.000541	CcSEcCtD
Etoricoxib—Urinary tract infection—Epirubicin—pancreatic cancer	0.000108	0.000541	CcSEcCtD
Etoricoxib—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000107	0.000537	CcSEcCtD
Etoricoxib—Dry mouth—Docetaxel—pancreatic cancer	0.000107	0.000537	CcSEcCtD
Etoricoxib—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000107	0.000537	CcSEcCtD
Etoricoxib—Asthenia—Gemcitabine—pancreatic cancer	0.000106	0.000532	CcSEcCtD
Etoricoxib—Haematuria—Epirubicin—pancreatic cancer	0.000106	0.000531	CcSEcCtD
Etoricoxib—Confusional state—Docetaxel—pancreatic cancer	0.000106	0.000531	CcSEcCtD
Etoricoxib—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000105	0.000527	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000105	0.000526	CcSEcCtD
Etoricoxib—Oedema—Docetaxel—pancreatic cancer	0.000105	0.000526	CcSEcCtD
Etoricoxib—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000105	0.000526	CcSEcCtD
Etoricoxib—Weight increased—Doxorubicin—pancreatic cancer	0.000105	0.000526	CcSEcCtD
Etoricoxib—Epistaxis—Epirubicin—pancreatic cancer	0.000104	0.000525	CcSEcCtD
Etoricoxib—Pruritus—Gemcitabine—pancreatic cancer	0.000104	0.000525	CcSEcCtD
Etoricoxib—Infection—Docetaxel—pancreatic cancer	0.000104	0.000523	CcSEcCtD
Etoricoxib—Sinusitis—Epirubicin—pancreatic cancer	0.000104	0.000522	CcSEcCtD
Etoricoxib—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000104	0.000521	CcSEcCtD
Etoricoxib—Diarrhoea—Irinotecan—pancreatic cancer	0.000104	0.000521	CcSEcCtD
Etoricoxib—Pneumonia—Doxorubicin—pancreatic cancer	0.000103	0.000518	CcSEcCtD
Etoricoxib—Shock—Docetaxel—pancreatic cancer	0.000103	0.000518	CcSEcCtD
Etoricoxib—Nervous system disorder—Docetaxel—pancreatic cancer	0.000103	0.000516	CcSEcCtD
Etoricoxib—Pruritus—Fluorouracil—pancreatic cancer	0.000103	0.000516	CcSEcCtD
Etoricoxib—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000102	0.000515	CcSEcCtD
Etoricoxib—Infestation NOS—Doxorubicin—pancreatic cancer	0.000102	0.000515	CcSEcCtD
Etoricoxib—Infestation—Doxorubicin—pancreatic cancer	0.000102	0.000515	CcSEcCtD
Etoricoxib—Skin disorder—Docetaxel—pancreatic cancer	0.000102	0.000511	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000102	0.00051	CcSEcCtD
Etoricoxib—Diarrhoea—Gemcitabine—pancreatic cancer	0.000101	0.000507	CcSEcCtD
Etoricoxib—Renal failure—Doxorubicin—pancreatic cancer	0.000101	0.000506	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.0001	0.000505	CcSEcCtD
Etoricoxib—Dizziness—Irinotecan—pancreatic cancer	0.0001	0.000503	CcSEcCtD
Etoricoxib—Haemoglobin—Epirubicin—pancreatic cancer	9.99e-05	0.000502	CcSEcCtD
Etoricoxib—Stomatitis—Doxorubicin—pancreatic cancer	9.98e-05	0.000502	CcSEcCtD
Etoricoxib—Jaundice—Doxorubicin—pancreatic cancer	9.98e-05	0.000502	CcSEcCtD
Etoricoxib—Anorexia—Docetaxel—pancreatic cancer	9.98e-05	0.000502	CcSEcCtD
Etoricoxib—Urinary tract infection—Doxorubicin—pancreatic cancer	9.95e-05	0.0005	CcSEcCtD
Etoricoxib—Conjunctivitis—Doxorubicin—pancreatic cancer	9.95e-05	0.0005	CcSEcCtD
Etoricoxib—Hepatitis—Epirubicin—pancreatic cancer	9.94e-05	0.0005	CcSEcCtD
Etoricoxib—Haemorrhage—Epirubicin—pancreatic cancer	9.94e-05	0.0005	CcSEcCtD
Etoricoxib—Diarrhoea—Fluorouracil—pancreatic cancer	9.92e-05	0.000499	CcSEcCtD
Etoricoxib—Hypoaesthesia—Epirubicin—pancreatic cancer	9.89e-05	0.000497	CcSEcCtD
Etoricoxib—Pharyngitis—Epirubicin—pancreatic cancer	9.86e-05	0.000496	CcSEcCtD
Etoricoxib—Urinary tract disorder—Epirubicin—pancreatic cancer	9.81e-05	0.000493	CcSEcCtD
Etoricoxib—Oedema peripheral—Epirubicin—pancreatic cancer	9.79e-05	0.000492	CcSEcCtD
Etoricoxib—Haematuria—Doxorubicin—pancreatic cancer	9.76e-05	0.000491	CcSEcCtD
Etoricoxib—Connective tissue disorder—Epirubicin—pancreatic cancer	9.76e-05	0.000491	CcSEcCtD
Etoricoxib—Urethral disorder—Epirubicin—pancreatic cancer	9.74e-05	0.00049	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Doxorubicin—pancreatic cancer	9.69e-05	0.000487	CcSEcCtD
Etoricoxib—Epistaxis—Doxorubicin—pancreatic cancer	9.66e-05	0.000486	CcSEcCtD
Etoricoxib—Vomiting—Irinotecan—pancreatic cancer	9.63e-05	0.000484	CcSEcCtD
Etoricoxib—Sinusitis—Doxorubicin—pancreatic cancer	9.61e-05	0.000483	CcSEcCtD
Etoricoxib—Dizziness—Fluorouracil—pancreatic cancer	9.59e-05	0.000482	CcSEcCtD
Etoricoxib—Visual impairment—Epirubicin—pancreatic cancer	9.58e-05	0.000481	CcSEcCtD
Etoricoxib—Rash—Irinotecan—pancreatic cancer	9.55e-05	0.00048	CcSEcCtD
Etoricoxib—Dermatitis—Irinotecan—pancreatic cancer	9.54e-05	0.000479	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	9.54e-05	0.000479	CcSEcCtD
Etoricoxib—Headache—Irinotecan—pancreatic cancer	9.48e-05	0.000477	CcSEcCtD
Etoricoxib—Insomnia—Docetaxel—pancreatic cancer	9.47e-05	0.000476	CcSEcCtD
Etoricoxib—Erythema multiforme—Epirubicin—pancreatic cancer	9.39e-05	0.000472	CcSEcCtD
Etoricoxib—Vomiting—Gemcitabine—pancreatic cancer	9.38e-05	0.000471	CcSEcCtD
Etoricoxib—Dyspnoea—Docetaxel—pancreatic cancer	9.33e-05	0.000469	CcSEcCtD
Etoricoxib—Somnolence—Docetaxel—pancreatic cancer	9.3e-05	0.000468	CcSEcCtD
Etoricoxib—Rash—Gemcitabine—pancreatic cancer	9.3e-05	0.000467	CcSEcCtD
Etoricoxib—Dermatitis—Gemcitabine—pancreatic cancer	9.29e-05	0.000467	CcSEcCtD
Etoricoxib—Eye disorder—Epirubicin—pancreatic cancer	9.29e-05	0.000467	CcSEcCtD
Etoricoxib—Tinnitus—Epirubicin—pancreatic cancer	9.26e-05	0.000466	CcSEcCtD
Etoricoxib—Haemoglobin—Doxorubicin—pancreatic cancer	9.24e-05	0.000465	CcSEcCtD
Etoricoxib—Headache—Gemcitabine—pancreatic cancer	9.24e-05	0.000464	CcSEcCtD
Etoricoxib—Flushing—Epirubicin—pancreatic cancer	9.22e-05	0.000464	CcSEcCtD
Etoricoxib—Cardiac disorder—Epirubicin—pancreatic cancer	9.22e-05	0.000464	CcSEcCtD
Etoricoxib—Vomiting—Fluorouracil—pancreatic cancer	9.22e-05	0.000464	CcSEcCtD
Etoricoxib—Dyspepsia—Docetaxel—pancreatic cancer	9.21e-05	0.000463	CcSEcCtD
Etoricoxib—Haemorrhage—Doxorubicin—pancreatic cancer	9.19e-05	0.000462	CcSEcCtD
Etoricoxib—Hepatitis—Doxorubicin—pancreatic cancer	9.19e-05	0.000462	CcSEcCtD
Etoricoxib—Hypoaesthesia—Doxorubicin—pancreatic cancer	9.15e-05	0.00046	CcSEcCtD
Etoricoxib—Rash—Fluorouracil—pancreatic cancer	9.14e-05	0.00046	CcSEcCtD
Etoricoxib—Dermatitis—Fluorouracil—pancreatic cancer	9.13e-05	0.000459	CcSEcCtD
Etoricoxib—Pharyngitis—Doxorubicin—pancreatic cancer	9.12e-05	0.000459	CcSEcCtD
Etoricoxib—Decreased appetite—Docetaxel—pancreatic cancer	9.1e-05	0.000457	CcSEcCtD
Etoricoxib—Headache—Fluorouracil—pancreatic cancer	9.08e-05	0.000457	CcSEcCtD
Etoricoxib—Urinary tract disorder—Doxorubicin—pancreatic cancer	9.08e-05	0.000456	CcSEcCtD
Etoricoxib—Oedema peripheral—Doxorubicin—pancreatic cancer	9.06e-05	0.000455	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Docetaxel—pancreatic cancer	9.04e-05	0.000454	CcSEcCtD
Etoricoxib—Connective tissue disorder—Doxorubicin—pancreatic cancer	9.03e-05	0.000454	CcSEcCtD
Etoricoxib—Fatigue—Docetaxel—pancreatic cancer	9.02e-05	0.000454	CcSEcCtD
Etoricoxib—Angiopathy—Epirubicin—pancreatic cancer	9.01e-05	0.000453	CcSEcCtD
Etoricoxib—Urethral disorder—Doxorubicin—pancreatic cancer	9.01e-05	0.000453	CcSEcCtD
Etoricoxib—Nausea—Irinotecan—pancreatic cancer	8.99e-05	0.000452	CcSEcCtD
Etoricoxib—Immune system disorder—Epirubicin—pancreatic cancer	8.97e-05	0.000451	CcSEcCtD
Etoricoxib—Mediastinal disorder—Epirubicin—pancreatic cancer	8.95e-05	0.00045	CcSEcCtD
Etoricoxib—Constipation—Docetaxel—pancreatic cancer	8.95e-05	0.00045	CcSEcCtD
Etoricoxib—Pain—Docetaxel—pancreatic cancer	8.95e-05	0.00045	CcSEcCtD
Etoricoxib—Arrhythmia—Epirubicin—pancreatic cancer	8.88e-05	0.000446	CcSEcCtD
Etoricoxib—Visual impairment—Doxorubicin—pancreatic cancer	8.86e-05	0.000445	CcSEcCtD
Etoricoxib—Alopecia—Epirubicin—pancreatic cancer	8.78e-05	0.000441	CcSEcCtD
Etoricoxib—Nausea—Gemcitabine—pancreatic cancer	8.76e-05	0.00044	CcSEcCtD
Etoricoxib—Mental disorder—Epirubicin—pancreatic cancer	8.7e-05	0.000438	CcSEcCtD
Etoricoxib—Erythema multiforme—Doxorubicin—pancreatic cancer	8.69e-05	0.000437	CcSEcCtD
Etoricoxib—Malnutrition—Epirubicin—pancreatic cancer	8.65e-05	0.000435	CcSEcCtD
Etoricoxib—Erythema—Epirubicin—pancreatic cancer	8.65e-05	0.000435	CcSEcCtD
Etoricoxib—Feeling abnormal—Docetaxel—pancreatic cancer	8.62e-05	0.000434	CcSEcCtD
Etoricoxib—Nausea—Fluorouracil—pancreatic cancer	8.61e-05	0.000433	CcSEcCtD
Etoricoxib—Eye disorder—Doxorubicin—pancreatic cancer	8.59e-05	0.000432	CcSEcCtD
Etoricoxib—Tinnitus—Doxorubicin—pancreatic cancer	8.57e-05	0.000431	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Docetaxel—pancreatic cancer	8.56e-05	0.00043	CcSEcCtD
Etoricoxib—Flushing—Doxorubicin—pancreatic cancer	8.53e-05	0.000429	CcSEcCtD
Etoricoxib—Cardiac disorder—Doxorubicin—pancreatic cancer	8.53e-05	0.000429	CcSEcCtD
Etoricoxib—Flatulence—Epirubicin—pancreatic cancer	8.52e-05	0.000429	CcSEcCtD
Etoricoxib—Dysgeusia—Epirubicin—pancreatic cancer	8.47e-05	0.000426	CcSEcCtD
Etoricoxib—Angiopathy—Doxorubicin—pancreatic cancer	8.34e-05	0.000419	CcSEcCtD
Etoricoxib—Muscle spasms—Epirubicin—pancreatic cancer	8.32e-05	0.000418	CcSEcCtD
Etoricoxib—Immune system disorder—Doxorubicin—pancreatic cancer	8.3e-05	0.000417	CcSEcCtD
Etoricoxib—Mediastinal disorder—Doxorubicin—pancreatic cancer	8.29e-05	0.000417	CcSEcCtD
Etoricoxib—Abdominal pain—Docetaxel—pancreatic cancer	8.27e-05	0.000416	CcSEcCtD
Etoricoxib—Arrhythmia—Doxorubicin—pancreatic cancer	8.21e-05	0.000413	CcSEcCtD
Etoricoxib—Vision blurred—Epirubicin—pancreatic cancer	8.15e-05	0.00041	CcSEcCtD
Etoricoxib—Alopecia—Doxorubicin—pancreatic cancer	8.12e-05	0.000408	CcSEcCtD
Etoricoxib—Mental disorder—Doxorubicin—pancreatic cancer	8.05e-05	0.000405	CcSEcCtD
Etoricoxib—Erythema—Doxorubicin—pancreatic cancer	8e-05	0.000402	CcSEcCtD
Etoricoxib—Malnutrition—Doxorubicin—pancreatic cancer	8e-05	0.000402	CcSEcCtD
Etoricoxib—Anaemia—Epirubicin—pancreatic cancer	7.99e-05	0.000402	CcSEcCtD
Etoricoxib—Agitation—Epirubicin—pancreatic cancer	7.95e-05	0.0004	CcSEcCtD
Etoricoxib—Flatulence—Doxorubicin—pancreatic cancer	7.89e-05	0.000396	CcSEcCtD
Etoricoxib—Dysgeusia—Doxorubicin—pancreatic cancer	7.84e-05	0.000394	CcSEcCtD
Etoricoxib—Hypersensitivity—Docetaxel—pancreatic cancer	7.71e-05	0.000388	CcSEcCtD
Etoricoxib—Muscle spasms—Doxorubicin—pancreatic cancer	7.69e-05	0.000387	CcSEcCtD
Etoricoxib—Palpitations—Epirubicin—pancreatic cancer	7.64e-05	0.000384	CcSEcCtD
Etoricoxib—Cough—Epirubicin—pancreatic cancer	7.55e-05	0.000379	CcSEcCtD
Etoricoxib—Vision blurred—Doxorubicin—pancreatic cancer	7.54e-05	0.000379	CcSEcCtD
Etoricoxib—Asthenia—Docetaxel—pancreatic cancer	7.51e-05	0.000378	CcSEcCtD
Etoricoxib—Hypertension—Epirubicin—pancreatic cancer	7.47e-05	0.000375	CcSEcCtD
Etoricoxib—Pruritus—Docetaxel—pancreatic cancer	7.4e-05	0.000372	CcSEcCtD
Etoricoxib—Anaemia—Doxorubicin—pancreatic cancer	7.4e-05	0.000372	CcSEcCtD
Etoricoxib—Chest pain—Epirubicin—pancreatic cancer	7.36e-05	0.00037	CcSEcCtD
Etoricoxib—Arthralgia—Epirubicin—pancreatic cancer	7.36e-05	0.00037	CcSEcCtD
Etoricoxib—Agitation—Doxorubicin—pancreatic cancer	7.35e-05	0.00037	CcSEcCtD
Etoricoxib—Anxiety—Epirubicin—pancreatic cancer	7.34e-05	0.000369	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	7.31e-05	0.000368	CcSEcCtD
Etoricoxib—Dry mouth—Epirubicin—pancreatic cancer	7.2e-05	0.000362	CcSEcCtD
Etoricoxib—Diarrhoea—Docetaxel—pancreatic cancer	7.16e-05	0.00036	CcSEcCtD
Etoricoxib—Confusional state—Epirubicin—pancreatic cancer	7.12e-05	0.000358	CcSEcCtD
Etoricoxib—Palpitations—Doxorubicin—pancreatic cancer	7.07e-05	0.000356	CcSEcCtD
Etoricoxib—Anaphylactic shock—Epirubicin—pancreatic cancer	7.06e-05	0.000355	CcSEcCtD
Etoricoxib—Oedema—Epirubicin—pancreatic cancer	7.06e-05	0.000355	CcSEcCtD
Etoricoxib—Infection—Epirubicin—pancreatic cancer	7.01e-05	0.000353	CcSEcCtD
Etoricoxib—Cough—Doxorubicin—pancreatic cancer	6.98e-05	0.000351	CcSEcCtD
Etoricoxib—Shock—Epirubicin—pancreatic cancer	6.95e-05	0.000349	CcSEcCtD
Etoricoxib—Nervous system disorder—Epirubicin—pancreatic cancer	6.92e-05	0.000348	CcSEcCtD
Etoricoxib—Dizziness—Docetaxel—pancreatic cancer	6.92e-05	0.000348	CcSEcCtD
Etoricoxib—Thrombocytopenia—Epirubicin—pancreatic cancer	6.91e-05	0.000347	CcSEcCtD
Etoricoxib—Hypertension—Doxorubicin—pancreatic cancer	6.91e-05	0.000347	CcSEcCtD
Etoricoxib—Skin disorder—Epirubicin—pancreatic cancer	6.86e-05	0.000345	CcSEcCtD
Etoricoxib—Chest pain—Doxorubicin—pancreatic cancer	6.81e-05	0.000343	CcSEcCtD
Etoricoxib—Arthralgia—Doxorubicin—pancreatic cancer	6.81e-05	0.000343	CcSEcCtD
Etoricoxib—Anxiety—Doxorubicin—pancreatic cancer	6.79e-05	0.000341	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	6.77e-05	0.00034	CcSEcCtD
Etoricoxib—Anorexia—Epirubicin—pancreatic cancer	6.73e-05	0.000338	CcSEcCtD
Etoricoxib—Dry mouth—Doxorubicin—pancreatic cancer	6.66e-05	0.000335	CcSEcCtD
Etoricoxib—Vomiting—Docetaxel—pancreatic cancer	6.65e-05	0.000335	CcSEcCtD
Etoricoxib—Rash—Docetaxel—pancreatic cancer	6.6e-05	0.000332	CcSEcCtD
Etoricoxib—Dermatitis—Docetaxel—pancreatic cancer	6.59e-05	0.000331	CcSEcCtD
Etoricoxib—Confusional state—Doxorubicin—pancreatic cancer	6.59e-05	0.000331	CcSEcCtD
Etoricoxib—Headache—Docetaxel—pancreatic cancer	6.56e-05	0.00033	CcSEcCtD
Etoricoxib—Oedema—Doxorubicin—pancreatic cancer	6.53e-05	0.000328	CcSEcCtD
Etoricoxib—Anaphylactic shock—Doxorubicin—pancreatic cancer	6.53e-05	0.000328	CcSEcCtD
Etoricoxib—Infection—Doxorubicin—pancreatic cancer	6.49e-05	0.000326	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	6.43e-05	0.000323	CcSEcCtD
Etoricoxib—Shock—Doxorubicin—pancreatic cancer	6.43e-05	0.000323	CcSEcCtD
Etoricoxib—Nervous system disorder—Doxorubicin—pancreatic cancer	6.41e-05	0.000322	CcSEcCtD
Etoricoxib—Thrombocytopenia—Doxorubicin—pancreatic cancer	6.4e-05	0.000322	CcSEcCtD
Etoricoxib—Insomnia—Epirubicin—pancreatic cancer	6.38e-05	0.000321	CcSEcCtD
Etoricoxib—Skin disorder—Doxorubicin—pancreatic cancer	6.34e-05	0.000319	CcSEcCtD
Etoricoxib—Dyspnoea—Epirubicin—pancreatic cancer	6.29e-05	0.000316	CcSEcCtD
Etoricoxib—Somnolence—Epirubicin—pancreatic cancer	6.28e-05	0.000316	CcSEcCtD
Etoricoxib—Anorexia—Doxorubicin—pancreatic cancer	6.23e-05	0.000313	CcSEcCtD
Etoricoxib—Nausea—Docetaxel—pancreatic cancer	6.22e-05	0.000313	CcSEcCtD
Etoricoxib—Dyspepsia—Epirubicin—pancreatic cancer	6.21e-05	0.000312	CcSEcCtD
Etoricoxib—Decreased appetite—Epirubicin—pancreatic cancer	6.14e-05	0.000309	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Epirubicin—pancreatic cancer	6.09e-05	0.000306	CcSEcCtD
Etoricoxib—Fatigue—Epirubicin—pancreatic cancer	6.09e-05	0.000306	CcSEcCtD
Etoricoxib—Pain—Epirubicin—pancreatic cancer	6.04e-05	0.000303	CcSEcCtD
Etoricoxib—Constipation—Epirubicin—pancreatic cancer	6.04e-05	0.000303	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	5.95e-05	0.000299	CcSEcCtD
Etoricoxib—Insomnia—Doxorubicin—pancreatic cancer	5.91e-05	0.000297	CcSEcCtD
Etoricoxib—Dyspnoea—Doxorubicin—pancreatic cancer	5.82e-05	0.000293	CcSEcCtD
Etoricoxib—Feeling abnormal—Epirubicin—pancreatic cancer	5.82e-05	0.000292	CcSEcCtD
Etoricoxib—Somnolence—Doxorubicin—pancreatic cancer	5.81e-05	0.000292	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Epirubicin—pancreatic cancer	5.77e-05	0.00029	CcSEcCtD
Etoricoxib—Dyspepsia—Doxorubicin—pancreatic cancer	5.75e-05	0.000289	CcSEcCtD
Etoricoxib—Decreased appetite—Doxorubicin—pancreatic cancer	5.68e-05	0.000285	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	5.64e-05	0.000284	CcSEcCtD
Etoricoxib—Fatigue—Doxorubicin—pancreatic cancer	5.63e-05	0.000283	CcSEcCtD
Etoricoxib—Urticaria—Epirubicin—pancreatic cancer	5.61e-05	0.000282	CcSEcCtD
Etoricoxib—Pain—Doxorubicin—pancreatic cancer	5.59e-05	0.000281	CcSEcCtD
Etoricoxib—Constipation—Doxorubicin—pancreatic cancer	5.59e-05	0.000281	CcSEcCtD
Etoricoxib—Abdominal pain—Epirubicin—pancreatic cancer	5.58e-05	0.000281	CcSEcCtD
Etoricoxib—Feeling abnormal—Doxorubicin—pancreatic cancer	5.38e-05	0.000271	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Doxorubicin—pancreatic cancer	5.34e-05	0.000269	CcSEcCtD
Etoricoxib—Hypersensitivity—Epirubicin—pancreatic cancer	5.2e-05	0.000261	CcSEcCtD
Etoricoxib—Urticaria—Doxorubicin—pancreatic cancer	5.19e-05	0.000261	CcSEcCtD
Etoricoxib—Abdominal pain—Doxorubicin—pancreatic cancer	5.16e-05	0.00026	CcSEcCtD
Etoricoxib—Asthenia—Epirubicin—pancreatic cancer	5.06e-05	0.000255	CcSEcCtD
Etoricoxib—Pruritus—Epirubicin—pancreatic cancer	4.99e-05	0.000251	CcSEcCtD
Etoricoxib—Diarrhoea—Epirubicin—pancreatic cancer	4.83e-05	0.000243	CcSEcCtD
Etoricoxib—Hypersensitivity—Doxorubicin—pancreatic cancer	4.81e-05	0.000242	CcSEcCtD
Etoricoxib—Asthenia—Doxorubicin—pancreatic cancer	4.69e-05	0.000236	CcSEcCtD
Etoricoxib—Dizziness—Epirubicin—pancreatic cancer	4.67e-05	0.000235	CcSEcCtD
Etoricoxib—Pruritus—Doxorubicin—pancreatic cancer	4.62e-05	0.000232	CcSEcCtD
Etoricoxib—Vomiting—Epirubicin—pancreatic cancer	4.49e-05	0.000226	CcSEcCtD
Etoricoxib—Diarrhoea—Doxorubicin—pancreatic cancer	4.47e-05	0.000225	CcSEcCtD
Etoricoxib—Rash—Epirubicin—pancreatic cancer	4.45e-05	0.000224	CcSEcCtD
Etoricoxib—Dermatitis—Epirubicin—pancreatic cancer	4.45e-05	0.000224	CcSEcCtD
Etoricoxib—Headache—Epirubicin—pancreatic cancer	4.42e-05	0.000222	CcSEcCtD
Etoricoxib—Dizziness—Doxorubicin—pancreatic cancer	4.32e-05	0.000217	CcSEcCtD
Etoricoxib—Nausea—Epirubicin—pancreatic cancer	4.19e-05	0.000211	CcSEcCtD
Etoricoxib—Vomiting—Doxorubicin—pancreatic cancer	4.15e-05	0.000209	CcSEcCtD
Etoricoxib—Rash—Doxorubicin—pancreatic cancer	4.12e-05	0.000207	CcSEcCtD
Etoricoxib—Dermatitis—Doxorubicin—pancreatic cancer	4.11e-05	0.000207	CcSEcCtD
Etoricoxib—Headache—Doxorubicin—pancreatic cancer	4.09e-05	0.000206	CcSEcCtD
Etoricoxib—Nausea—Doxorubicin—pancreatic cancer	3.88e-05	0.000195	CcSEcCtD
Etoricoxib—MAPK14—Immune System—TSC2—pancreatic cancer	2.06e-05	0.000223	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GLP1R—pancreatic cancer	2.05e-05	0.000223	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ARG2—pancreatic cancer	2.05e-05	0.000222	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CNR1—pancreatic cancer	2.05e-05	0.000222	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—NRAS—pancreatic cancer	2.05e-05	0.000222	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—SLC2A2—pancreatic cancer	2.04e-05	0.000221	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PRSS1—pancreatic cancer	2.02e-05	0.000219	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—DPYD—pancreatic cancer	2.02e-05	0.000219	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.02e-05	0.000218	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—JAG1—pancreatic cancer	1.98e-05	0.000215	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GCG—pancreatic cancer	1.98e-05	0.000214	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—TYMP—pancreatic cancer	1.97e-05	0.000213	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.95e-05	0.000211	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TGFB1—pancreatic cancer	1.94e-05	0.00021	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—SLC2A2—pancreatic cancer	1.92e-05	0.000208	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—SRC—pancreatic cancer	1.92e-05	0.000208	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TGFB1—pancreatic cancer	1.9e-05	0.000206	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—EGFR—pancreatic cancer	1.9e-05	0.000206	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—AGTR1—pancreatic cancer	1.89e-05	0.000205	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD44—pancreatic cancer	1.88e-05	0.000204	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—NFKBIA—pancreatic cancer	1.88e-05	0.000203	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HSPA1A—pancreatic cancer	1.87e-05	0.000203	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—STK11—pancreatic cancer	1.86e-05	0.000202	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—NOTCH1—pancreatic cancer	1.85e-05	0.0002	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—NRAS—pancreatic cancer	1.84e-05	0.0002	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.84e-05	0.0002	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TNF—pancreatic cancer	1.81e-05	0.000196	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—TYMP—pancreatic cancer	1.81e-05	0.000196	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—EGF—pancreatic cancer	1.8e-05	0.000195	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—KRAS—pancreatic cancer	1.8e-05	0.000195	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—TYMP—pancreatic cancer	1.79e-05	0.000194	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.77e-05	0.000192	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—KRAS—pancreatic cancer	1.76e-05	0.000191	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ARG2—pancreatic cancer	1.75e-05	0.00019	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—PPARG—pancreatic cancer	1.75e-05	0.000189	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—EGFR—pancreatic cancer	1.68e-05	0.000182	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CDH1—pancreatic cancer	1.67e-05	0.000181	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SMAD4—pancreatic cancer	1.63e-05	0.000177	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.62e-05	0.000176	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—PIK3CA—pancreatic cancer	1.62e-05	0.000175	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PIK3CD—pancreatic cancer	1.6e-05	0.000173	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HES1—pancreatic cancer	1.59e-05	0.000172	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—KRAS—pancreatic cancer	1.59e-05	0.000172	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GLP1R—pancreatic cancer	1.59e-05	0.000172	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CD44—pancreatic cancer	1.58e-05	0.000171	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TP53—pancreatic cancer	1.57e-05	0.00017	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.56e-05	0.000169	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—DPYD—pancreatic cancer	1.56e-05	0.000169	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.55e-05	0.000167	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—TYMP—pancreatic cancer	1.53e-05	0.000166	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—HRAS—pancreatic cancer	1.53e-05	0.000165	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GCG—pancreatic cancer	1.51e-05	0.000164	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—HRAS—pancreatic cancer	1.5e-05	0.000162	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SMAD4—pancreatic cancer	1.49e-05	0.000161	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CD44—pancreatic cancer	1.49e-05	0.000161	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	1.48e-05	0.00016	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.48e-05	0.00016	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.46e-05	0.000159	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—PIK3CA—pancreatic cancer	1.46e-05	0.000158	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GLP1R—pancreatic cancer	1.46e-05	0.000158	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HES1—pancreatic cancer	1.45e-05	0.000157	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GLP1R—pancreatic cancer	1.45e-05	0.000157	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—DPYD—pancreatic cancer	1.43e-05	0.000155	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GCG—pancreatic cancer	1.42e-05	0.000154	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—STK11—pancreatic cancer	1.42e-05	0.000154	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—DPYD—pancreatic cancer	1.42e-05	0.000154	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.41e-05	0.000153	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TERT—pancreatic cancer	1.4e-05	0.000151	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PIK3CB—pancreatic cancer	1.39e-05	0.000151	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	1.36e-05	0.000147	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.35e-05	0.000147	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	1.35e-05	0.000146	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—HRAS—pancreatic cancer	1.35e-05	0.000146	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—AKT1—pancreatic cancer	1.35e-05	0.000146	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—STK11—pancreatic cancer	1.34e-05	0.000145	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.34e-05	0.000145	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.34e-05	0.000145	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HIF1A—pancreatic cancer	1.33e-05	0.000145	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TSC2—pancreatic cancer	1.33e-05	0.000144	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—AKT1—pancreatic cancer	1.32e-05	0.000143	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—APOE—pancreatic cancer	1.3e-05	0.000141	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.29e-05	0.00014	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.29e-05	0.000139	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—KDR—pancreatic cancer	1.28e-05	0.000138	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TERT—pancreatic cancer	1.27e-05	0.000138	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.26e-05	0.000137	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GLP1R—pancreatic cancer	1.24e-05	0.000134	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CTNNB1—pancreatic cancer	1.24e-05	0.000134	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—TYMS—pancreatic cancer	1.22e-05	0.000133	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HIF1A—pancreatic cancer	1.22e-05	0.000132	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—DPYD—pancreatic cancer	1.22e-05	0.000132	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TSC2—pancreatic cancer	1.21e-05	0.000132	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NFKBIA—pancreatic cancer	1.21e-05	0.000131	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PTEN—pancreatic cancer	1.2e-05	0.00013	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NOTCH1—pancreatic cancer	1.2e-05	0.00013	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—AKT1—pancreatic cancer	1.19e-05	0.000129	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—APOE—pancreatic cancer	1.19e-05	0.000129	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.18e-05	0.000128	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PIK3CG—pancreatic cancer	1.18e-05	0.000127	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.17e-05	0.000127	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—EGF—pancreatic cancer	1.16e-05	0.000126	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	1.15e-05	0.000125	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—TYMS—pancreatic cancer	1.15e-05	0.000125	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CD44—pancreatic cancer	1.15e-05	0.000124	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.14e-05	0.000124	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.12e-05	0.000122	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—SRC—pancreatic cancer	1.12e-05	0.000121	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.11e-05	0.00012	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.1e-05	0.000119	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GCG—pancreatic cancer	1.1e-05	0.000119	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOTCH1—pancreatic cancer	1.1e-05	0.000119	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—STAT3—pancreatic cancer	1.08e-05	0.000117	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—NRAS—pancreatic cancer	1.07e-05	0.000116	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—EGF—pancreatic cancer	1.06e-05	0.000115	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CD44—pancreatic cancer	1.05e-05	0.000114	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CD44—pancreatic cancer	1.05e-05	0.000113	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PIK3CD—pancreatic cancer	1.03e-05	0.000112	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—STK11—pancreatic cancer	1.03e-05	0.000112	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.02e-05	0.000111	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.01e-05	0.00011	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GCG—pancreatic cancer	1.01e-05	0.000109	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1e-05	0.000109	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GCG—pancreatic cancer	1e-05	0.000109	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—APOE—pancreatic cancer	9.95e-06	0.000108	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—MYC—pancreatic cancer	9.95e-06	0.000108	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—EGFR—pancreatic cancer	9.79e-06	0.000106	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	9.7e-06	0.000105	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GLP1R—pancreatic cancer	9.53e-06	0.000103	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—STK11—pancreatic cancer	9.5e-06	0.000103	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PIK3CD—pancreatic cancer	9.43e-06	0.000102	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—STK11—pancreatic cancer	9.42e-06	0.000102	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	9.42e-06	0.000102	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—DPYD—pancreatic cancer	9.38e-06	0.000102	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—APOE—pancreatic cancer	9.37e-06	0.000101	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—KRAS—pancreatic cancer	9.24e-06	0.0001	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PIK3CB—pancreatic cancer	9.01e-06	9.76e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PIK3CG—pancreatic cancer	8.98e-06	9.73e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CD44—pancreatic cancer	8.93e-06	9.67e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	8.9e-06	9.64e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—TYMS—pancreatic cancer	8.89e-06	9.62e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	8.84e-06	9.58e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.75e-06	9.47e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PPARG—pancreatic cancer	8.67e-06	9.39e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.67e-06	9.38e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCL8—pancreatic cancer	8.66e-06	9.37e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GCG—pancreatic cancer	8.56e-06	9.27e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PIK3CA—pancreatic cancer	8.49e-06	9.2e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PIK3CG—pancreatic cancer	8.46e-06	9.16e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CASP3—pancreatic cancer	8.29e-06	8.97e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PIK3CB—pancreatic cancer	8.22e-06	8.9e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—TYMS—pancreatic cancer	8.17e-06	8.85e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PPARG—pancreatic cancer	8.16e-06	8.84e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—TYMS—pancreatic cancer	8.1e-06	8.78e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCND1—pancreatic cancer	8.06e-06	8.73e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—STK11—pancreatic cancer	8.05e-06	8.72e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CTNNB1—pancreatic cancer	7.99e-06	8.65e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PIK3CD—pancreatic cancer	7.9e-06	8.55e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HRAS—pancreatic cancer	7.86e-06	8.51e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MMP9—pancreatic cancer	7.83e-06	8.48e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PTEN—pancreatic cancer	7.78e-06	8.43e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.56e-06	8.18e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PIK3CD—pancreatic cancer	7.43e-06	8.05e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CTNNB1—pancreatic cancer	7.29e-06	7.89e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—APOE—pancreatic cancer	7.23e-06	7.83e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SRC—pancreatic cancer	7.22e-06	7.82e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PTEN—pancreatic cancer	7.1e-06	7.69e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—VEGFA—pancreatic cancer	7.03e-06	7.61e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—STAT3—pancreatic cancer	6.96e-06	7.54e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NRAS—pancreatic cancer	6.94e-06	7.52e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—AKT1—pancreatic cancer	6.94e-06	7.51e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—TYMS—pancreatic cancer	6.93e-06	7.5e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—AKT1—pancreatic cancer	6.9e-06	7.47e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CD44—pancreatic cancer	6.89e-06	7.46e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PIK3CB—pancreatic cancer	6.88e-06	7.45e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.84e-06	7.41e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—APOE—pancreatic cancer	6.65e-06	7.2e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GCG—pancreatic cancer	6.61e-06	7.16e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—APOE—pancreatic cancer	6.59e-06	7.14e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SRC—pancreatic cancer	6.59e-06	7.13e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	6.52e-06	7.06e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	6.48e-06	7.02e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MYC—pancreatic cancer	6.47e-06	7.01e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TGFB1—pancreatic cancer	6.45e-06	6.99e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGS2—pancreatic cancer	6.42e-06	6.95e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—STAT3—pancreatic cancer	6.35e-06	6.88e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NRAS—pancreatic cancer	6.34e-06	6.86e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—EGFR—pancreatic cancer	6.33e-06	6.85e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PPARG—pancreatic cancer	6.3e-06	6.82e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.24e-06	6.76e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—STK11—pancreatic cancer	6.21e-06	6.73e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	6e-06	6.5e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—KRAS—pancreatic cancer	5.98e-06	6.47e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	5.95e-06	6.44e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PTEN—pancreatic cancer	5.95e-06	6.44e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MYC—pancreatic cancer	5.9e-06	6.39e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TGFB1—pancreatic cancer	5.89e-06	6.38e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PPARG—pancreatic cancer	5.79e-06	6.27e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—EGFR—pancreatic cancer	5.77e-06	6.25e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PPARG—pancreatic cancer	5.74e-06	6.22e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	5.73e-06	6.21e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—APOE—pancreatic cancer	5.63e-06	6.1e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTEN—pancreatic cancer	5.6e-06	6.06e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PIK3CA—pancreatic cancer	5.49e-06	5.95e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—KRAS—pancreatic cancer	5.45e-06	5.91e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—TYMS—pancreatic cancer	5.34e-06	5.79e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.33e-06	5.77e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TP53—pancreatic cancer	5.31e-06	5.75e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	5.27e-06	5.71e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	5.23e-06	5.66e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	5.08e-06	5.5e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HRAS—pancreatic cancer	5.08e-06	5.5e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PIK3CA—pancreatic cancer	5.01e-06	5.43e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	5e-06	5.41e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGS2—pancreatic cancer	4.95e-06	5.36e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PPARG—pancreatic cancer	4.91e-06	5.31e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HRAS—pancreatic cancer	4.63e-06	5.02e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	4.6e-06	4.98e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	4.56e-06	4.94e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGS2—pancreatic cancer	4.56e-06	4.93e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGS2—pancreatic cancer	4.52e-06	4.89e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—AKT1—pancreatic cancer	4.49e-06	4.86e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	4.47e-06	4.84e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—APOE—pancreatic cancer	4.35e-06	4.71e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTEN—pancreatic cancer	4.32e-06	4.68e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PIK3CA—pancreatic cancer	4.2e-06	4.54e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—AKT1—pancreatic cancer	4.09e-06	4.43e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTEN—pancreatic cancer	3.97e-06	4.3e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	3.95e-06	4.28e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTEN—pancreatic cancer	3.94e-06	4.27e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	3.92e-06	4.25e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	3.89e-06	4.22e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGS2—pancreatic cancer	3.86e-06	4.18e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PPARG—pancreatic cancer	3.79e-06	4.1e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.45e-06	3.73e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—AKT1—pancreatic cancer	3.43e-06	3.71e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTEN—pancreatic cancer	3.37e-06	3.64e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—AKT1—pancreatic cancer	3.23e-06	3.49e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	3.05e-06	3.3e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.01e-06	3.26e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.98e-06	3.23e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	2.8e-06	3.04e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	2.78e-06	3.01e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.6e-06	2.81e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—AKT1—pancreatic cancer	2.49e-06	2.7e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	2.37e-06	2.57e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—AKT1—pancreatic cancer	2.29e-06	2.48e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—AKT1—pancreatic cancer	2.27e-06	2.46e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.94e-06	2.1e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.83e-06	1.98e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.5e-06	1.62e-05	CbGpPWpGaD
